0001562180-22-005383.txt : 20220628
0001562180-22-005383.hdr.sgml : 20220628
20220628191621
ACCESSION NUMBER: 0001562180-22-005383
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220624
FILED AS OF DATE: 20220628
DATE AS OF CHANGE: 20220628
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brege Laura
CENTRAL INDEX KEY: 0001365619
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40236
FILM NUMBER: 221051410
MAIL ADDRESS:
STREET 1: C/O ONYX PHARMACEUTICALS, INC.
STREET 2: 2100 POWELL STREET
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edgewise Therapeutics, Inc.
CENTRAL INDEX KEY: 0001710072
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 821725586
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3415 COLORADO AVE.
CITY: BOULDER
STATE: CO
ZIP: 80303
BUSINESS PHONE: 303-735-8373
MAIL ADDRESS:
STREET 1: 3415 COLORADO AVE.
CITY: BOULDER
STATE: CO
ZIP: 80303
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2022-06-24
false
0001710072
Edgewise Therapeutics, Inc.
EWTX
0001365619
Brege Laura
C/O EDGEWISE THERAPEUTICS, INC.
3145 COLORADO AVE
BOULDER
CO
80303
true
false
false
false
Stock Option (Right to Buy)
8.53
2022-06-24
4
A
false
42087.00
0.00
A
2023-06-08
2032-06-24
Common Stock
42087.00
42087.00
D
100% of the Stock Options granted on June 24, 2022 will become vested on the earlier of (i) June 24, 2023 or (ii) the business day prior to the date of the 2023 annual meeting of stockholders.
/s/John R. Moore Attorney-in-Fact for Laura A. Brege
2022-06-28